(PharmaNewsWire.Com, May 21, 2021 ) The global laboratory mixers market size is projected to reach USD 2.1 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 3.7% during the forecast period growth in the laboratory mixers market is majorly driven by rising increasing research activity in...
(PharmaNewsWire.Com, May 21, 2021 ) The negative pressure wound therapy market is expected to reach USD 2, 724.2 million by 2023, from USD 2,113.6 million in 2018, at a CAGR of 5.2%. Negative Pressure Wound Therapy (NPWT) devices are used to treat chronic wounds, such as diabetic ulcers, pressure...
(PharmaNewsWire.Com, May 21, 2021 ) Growth in the overall market can largely be attributed to factors such as increasing advancements in wireless communication technologies, growing internet penetration, increasing utilization of connected devices in the management of chronic diseases, rising adoption...
(PharmaNewsWire.Com, May 21, 2021 ) The veterinary care market is expected to foresee positive trends throughout the forecast period. Substantial market growth can be attributed to the rising initiatives undertaken by the regulatory authorities. Government authorities collaborate with veterinarians...
(PharmaNewsWire.Com, May 21, 2021 ) This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics,...
(PharmaNewsWire.Com, May 21, 2021 ) The increasing demand for blood & blood components, rising government support for research activities and clinical trials, and technological advancements in freezers & refrigerators are the major factors driving the growth of the market. Untapped emerging regions...
(PharmaNewsWire.Com, May 21, 2021 ) The Parkinson’s disease treatment market was valued at USD 3.99 billion in 2016 and expected to grow at a CAGR of 6.1% from 2017 to 2022 to reach USD 5.69 billion in 2022. The carbidopa/levodopa drug class is projected to register highest CAGR during forecast period....
(PharmaNewsWire.Com, May 21, 2021 ) Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism, growing dental tourism, rising incidences of dental caries and other periodontal diseases and increasing outsourcing of certain manufacturing functions to dental...
(PharmaNewsWire.Com, May 21, 2021 ) The global vascular access devices market is projected to reach USD 5.45 Million by 2022 from USD 3.87 Million in 2017, at a CAGR of 7.1% during the forecast period. This is an emerging and fragmented market with various regional and national players. In 2016,...
(PharmaNewsWire.Com, May 21, 2021 ) The growth of this market is mainly driven by the growth in associated equipment markets, rising focus on preventive medical equipment maintenance, adoption of innovative funding mechanism, and the growing purchase of refurbished medical equipment.Independent Service...
(PharmaNewsWire.Com, May 21, 2021 ) The European medical equipment maintenance market is expected to reach USD 8.93 Billion by 2022 from USD 6.29 in 2016, at a CAGR of 6.1% during the forecast period.The growth of the market is attributed to rising focus on preventive maintenance. Preventive maintenance...
(PharmaNewsWire.Com, May 21, 2021 ) The companion animal diagnostics market is projected to reach USD 3.0 billion by 2025 from USD 1.8 billion in 2020, at a CAGR of 9.8%. The growth in this market is driven by growth in the companion animal population, rising demand for pet insurance, and increasing...
(PharmaNewsWire.Com, May 21, 2021 ) The global protein assays market is expected to reach USD 2.41 Billion by 2022 from USD 1.42 Billion in 2017, at a CAGR of 11.1% from 2017 to 2022. The increasing pharmaceutical & biotech R&D expenditure and favorable government funding scenario for proteomics...
(PharmaNewsWire.Com, May 21, 2021 ) The growth of the market during the forecast period is mainly driven by the increase in the avian diseases outbreak and zoonotic diseases, increasing adoption of vaccinations, diagnostic monitoring of birds for the presence of disease pathogens, and the rising...
(PharmaNewsWire.Com, May 21, 2021 ) The miRNA sequencing and assay market is projected to reach USD 343 million by 2024 from USD 182 million in 2018, at a CAGR of 11.2%. Growth in this market is driven by factors such as the advantages of miRNA sequencing over other technologies, increasing research...
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
